magent
Deterministic published-formula arithmetic plus ICD-10-CM, RxNorm, and LOINC. Pay in USDC on Base via x402.
Searchofflineeip155:8453Exactvia cdp
Iwg2-adAlzheimerNeurologyDementiaCalculator
Calls · 30d
2→ 0%
This endpoint's own trailing-30-day call count, as published by the upstream catalog and snapshotted daily. 8 snapshots so far.
$13.75
Verified settled volume
2,750 settlements proven x402 by their on-chain EIP-3009 marker.
$0.0050
Listed price
As published in the catalog. Always read the live 402 before paying.
2
Calls · 30d
Upstream's own call count for this endpoint, not ours.
1
Unique payers · 30d
Last called 2026-09-02 01:19Z
—
Upstream on-chain volume
Reported by the source catalog.
Paid to
0x836Be278f1739fB4308091cD1852F7971Bc19Ee2The wallet the 402 directs payment to. Its whole payment record — every payer, every chain — is on the merchant page.
Asset 0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913
Provider
The payTo wallet does not resolve to a registered ERC-8004 agent. That is not a verdict on the service — most of the catalog is unregistered.
Live 402 challenge
Captured by the enrichment pass, not read just now. Prices can change — always read the 402 the endpoint answers with.
{
"error": "PAYMENT-SIGNATURE header is required",
"accepts": [
{
"asset": "0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913",
"extra": {
"name": "USD Coin",
"version": "2",
"paymentFlow": "upfront",
"resourceUrl": "https://api.magentlab.com/api/calc/iwg2_ad",
"assetTransferMethod": "eip3009"
},
"payTo": "0x836Be278f1739fB4308091cD1852F7971Bc19Ee2",
"amount": "5000",
"scheme": "exact",
"network": "eip155:8453",
"maxTimeoutSeconds": 600
},
{
"asset": "0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913",
"extra": {
"name": "USD Coin",
"version": "2",
"withdrawDelay": 86400,
"receiverAuthorizer": "0x3721824a31197dcDD2984cF43b92B6cc8A87c0Fb",
"assetTransferMethod": "eip3009"
},
"payTo": "0x836Be278f1739fB4308091cD1852F7971Bc19Ee2",
"amount": "5000",
"scheme": "batch-settlement",
"network": "eip155:8453",
"maxTimeoutSeconds": 600
}
],
"resource": {
"url": "https://api.magentlab.com/api/calc/iwg2_ad",
"tags": [
"iwg2-ad",
"alzheimer",
"neurology",
"dementia",
"calculator"
],
"mimeType": "application/json",
"description": "Dubois 2014 IWG-2 typical AD research criteria. typical_ad iff early hippocampal-type episodic memory, no better explanation, and in-vivo AD pathology (CSF Abeta1-42 plus T-tau or P-tau, amyloid PET, or a PSEN1/PSEN2/APP mutation). Typical AD only; not atypical phenotypes. Not NINCDS-ADRDA, not NIA-AA ATN, not DSM. magent does not examine the patient, assay CSF, or read PET. Not a diagnosis or medical device.",
"serviceName": "magent"
},
"extensions": {
"bazaar": {
"info": {
"input": {
"type": "http",
"method": "GET",
"queryParams": {
"amyloid_pet": false,
"csf_abeta_and_tau": true,
"early_episodic_memory": true,
"no_better_explanation": true,
"autosomal_dominant_mutation": false
}
},
"output": {
"type": "json",
"example": {
"formula": "iwg2_ad",
"citation": {
"id": "dubois-2014",
"doi": "10.1016/S1474-4422(14)70090-0",
"pmid": "24849861",
"title": "Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria",
"source": "Lancet Neurol. 2014;13(6):614-629",
"authors": "Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, DeKosky ST, Gauthier S, Selkoe D, Bateman R, Cappa S, Crutch S, Engelborghs S, Frisoni GB, Fox NC, Galasko D, Habert MO, Jicha GA, Nordberg A, Pasquier F, Rabinovici G, Robert P, Rowe C, Salloway S, Sarazin M, Epelbaum S, de Souza LC, Vellas B, Visser PJ, Schneider L, Stern Y, Scheltens P, Cummings JL"
},
"criteria": [
{
"met": true,
"factor": "early_episodic_memory"
},
{
"met": true,
"factor": "csf_abeta_and_tau"
},
{
"met": false,
"factor": "amyloid_pet"
},
{
"met": false,
"factor": "autosomal_dominant_mutation"
},
{
"met": true,
"factor": "no_better_explanation"
},
{
"met": true,
"factor": "in_vivo_pathology"
}
],
"disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
"typical_ad": true,
"in_vivo_pathology": true,
"formula_expression": "typical_ad iff no_better_explanation AND early_episodic_memory AND (csf_abeta_and_tau OR amyloid_pet OR autosomal_dominant_mutation) (Dubois 2014 IWG-2 typical AD). Not NINCDS-ADRDA. Not NIA-AA. Not DSM. magent does not examine the patient or assay CSF/PET."
}
},
"iconUrl": "https://api.magentlab.com/favicon.ico"
},
"schema": {
"type": "object",
"$schema": "https://json-schema.org/draft/2020-12/schema",
"required": [
"input"
],
"properties": {
"input": {
"type": "object",
"required": [
"type",
"method"
],
"properties": {
"type": {
"type": "string",
"const": "http"
},
"method": {
"enum": [
"GET",
"HEAD",
"DELETE"
],
"type": "string"
},
"headers": {
"type": "object",
"additionalProperties": {
"type": "string"
}
},
"queryParams": {
"type": "object",
"required": [
"early_episodic_memory",
"csf_abeta_and_tau",
"amyloid_pet",
"autosomal_dominant_mutation",
"no_better_explanation"
],
"properties": {
"amyloid_pet": {
"type": "boolean",
"description": "Increased tracer retention on amyloid PET, as assigned by the caller (Dubois 2014 IWG-2 in-vivo AD pathology). true or false. magent does not read PET."
},
"csf_abeta_and_tau": {
"type": "boolean",
"description": "Decreased Aβ1-42 together with increased T-tau or P-tau in CSF, as assigned by the caller (Dubois 2014 IWG-2 in-vivo AD pathology). true or false. magent does not assay CSF."
},
"early_episodic_memory": {
"type": "boolean",
"description": "Early and significant episodic memory impairment of the hippocampal type (IWG-2 specific phenotype for typical AD), as assigned by the caller. true or false. magent does not examine the patient."
},
"no_better_explanation": {
"type": "boolean",
"description": "Exclusion of other disorders that could account for the phenotype, as assigned by the caller (Dubois 2014 IWG-2). true or false. magent does not examine the patient."
},
"autosomal_dominant_mutation": {
"type": "boolean",
"description": "Proven AD autosomal-dominant mutation in PSEN1, PSEN2, or APP, as assigned by the caller (Dubois 2014 IWG-2 in-vivo AD pathology). true or false. magent does not sequence genes."
}
}
}
},
"additionalProperties": false
},
"output": {
"type": "object",
"required": [
"type"
],
"properties": {
"type": {
"type": "string"
},
"example": {
"type": "object"
}
}
}
}
}
}
},
"x402Version": 2
}Accepts
The payment requirements as published to the catalog. Read the live 402 before paying — a price here is a claim, not a quote.
0.005USDC≈ $0.005 USD
on Base · exact scheme
Pay 0.005 USDC on Base to 0x836B…19Ee2. The signed payment is good for 10 minutes.
- Paid to
- 0x836B…19Ee2
- USD Coin contract
- 0x8335…02913
- Payment window
- 10 minutes
- As published
- 5000 smallest units
The catalog’s raw entry
[
{
"asset": "0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913",
"extra": {
"name": "USD Coin",
"version": "2",
"paymentFlow": "upfront",
"resourceUrl": "https://api.magentlab.com/api/calc/iwg2_ad",
"assetTransferMethod": "eip3009"
},
"payTo": "0x836Be278f1739fB4308091cD1852F7971Bc19Ee2",
"amount": "5000",
"scheme": "exact",
"network": "eip155:8453",
"maxTimeoutSeconds": 600
}
]Extensions
{
"bazaar": {
"info": {
"input": {
"body": {
"items": [
{
"amyloid_pet": false,
"csf_abeta_and_tau": true,
"early_episodic_memory": true,
"no_better_explanation": true,
"autosomal_dominant_mutation": false
},
{
"amyloid_pet": false,
"csf_abeta_and_tau": true,
"early_episodic_memory": true,
"no_better_explanation": true,
"autosomal_dominant_mutation": false
}
]
},
"type": "http",
"method": "POST"
},
"output": {
"type": "json",
"example": {
"path": "/api/calc/iwg2_ad",
"count": 2,
"items": [
{
"formula": "iwg2_ad",
"citation": {
"id": "dubois-2014",
"doi": "10.1016/S1474-4422(14)70090-0",
"pmid": "24849861",
"title": "Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria",
"source": "Lancet Neurol. 2014;13(6):614-629",
"authors": "Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, DeKosky ST, Gauthier S, Selkoe D, Bateman R, Cappa S, Crutch S, Engelborghs S, Frisoni GB, Fox NC, Galasko D, Habert MO, Jicha GA, Nordberg A, Pasquier F, Rabinovici G, Robert P, Rowe C, Salloway S, Sarazin M, Epelbaum S, de Souza LC, Vellas B, Visser PJ, Schneider L, Stern Y, Scheltens P, Cummings JL"
},
"criteria": [
{
"met": true,
"factor": "early_episodic_memory"
},
{
"met": true,
"factor": "csf_abeta_and_tau"
},
{
"met": false,
"factor": "amyloid_pet"
},
{
"met": false,
"factor": "autosomal_dominant_mutation"
},
{
"met": true,
"factor": "no_better_explanation"
},
{
"met": true,
"factor": "in_vivo_pathology"
}
],
"disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
"typical_ad": true,
"in_vivo_pathology": true,
"formula_expression": "typical_ad iff no_better_explanation AND early_episodic_memory AND (csf_abeta_and_tau OR amyloid_pet OR autosomal_dominant_mutation) (Dubois 2014 IWG-2 typical AD). Not NINCDS-ADRDA. Not NIA-AA. Not DSM. magent does not examine the patient or assay CSF/PET."
},
{
"formula": "iwg2_ad",
"citation": {
"id": "dubois-2014",
"doi": "10.1016/S1474-4422(14)70090-0",
"pmid": "24849861",
"title": "Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria",
"source": "Lancet Neurol. 2014;13(6):614-629",
"authors": "Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, DeKosky ST, Gauthier S, Selkoe D, Bateman R, Cappa S, Crutch S, Engelborghs S, Frisoni GB, Fox NC, Galasko D, Habert MO, Jicha GA, Nordberg A, Pasquier F, Rabinovici G, Robert P, Rowe C, Salloway S, Sarazin M, Epelbaum S, de Souza LC, Vellas B, Visser PJ, Schneider L, Stern Y, Scheltens P, Cummings JL"
},
"criteria": [
{
"met": true,
"factor": "early_episodic_memory"
},
{
"met": true,
"factor": "csf_abeta_and_tau"
},
{
"met": false,
"factor": "amyloid_pet"
},
{
"met": false,
"factor": "autosomal_dominant_mutation"
},
{
"met": true,
"factor": "no_better_explanation"
},
{
"met": true,
"factor": "in_vivo_pathology"
}
],
"disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
"typical_ad": true,
"in_vivo_pathology": true,
"formula_expression": "typical_ad iff no_better_explanation AND early_episodic_memory AND (csf_abeta_and_tau OR amyloid_pet OR autosomal_dominant_mutation) (Dubois 2014 IWG-2 typical AD). Not NINCDS-ADRDA. Not NIA-AA. Not DSM. magent does not examine the patient or assay CSF/PET."
}
]
}
},
"iconUrl": "https://api.magentlab.com/favicon.ico"
},
"schema": {
"type": "object",
"$schema": "https://json-schema.org/draft/2020-12/schema",
"required": [
"input"
],
"properties": {
"input": {
"type": "object",
"required": [
"type",
"method"
],
"properties": {
"body": {
"type": "object",
"required": [
"items"
],
"properties": {
"items": {
"type": "array",
"items": {
"type": "object",
"required": [
"early_episodic_memory",
"csf_abeta_and_tau",
"amyloid_pet",
"autosomal_dominant_mutation",
"no_better_explanation"
],
"properties": {
"amyloid_pet": {
"type": "boolean",
"description": "Increased tracer retention on amyloid PET, as assigned by the caller (Dubois 2014 IWG-2 in-vivo AD pathology). true or false. magent does not read PET."
},
"csf_abeta_and_tau": {
"type": "boolean",
"description": "Decreased Aβ1-42 together with increased T-tau or P-tau in CSF, as assigned by the caller (Dubois 2014 IWG-2 in-vivo AD pathology). true or false. magent does not assay CSF."
},
"early_episodic_memory": {
"type": "boolean",
"description": "Early and significant episodic memory impairment of the hippocampal type (IWG-2 specific phenotype for typical AD), as assigned by the caller. true or false. magent does not examine the patient."
},
"no_better_explanation": {
"type": "boolean",
"description": "Exclusion of other disorders that could account for the phenotype, as assigned by the caller (Dubois 2014 IWG-2). true or false. magent does not examine the patient."
},
"autosomal_dominant_mutation": {
"type": "boolean",
"description": "Proven AD autosomal-dominant mutation in PSEN1, PSEN2, or APP, as assigned by the caller (Dubois 2014 IWG-2 in-vivo AD pathology). true or false. magent does not sequence genes."
}
}
},
"maxItems": 25,
"minItems": 1
}
},
"additionalProperties": false
},
"type": {
"type": "string",
"const": "http"
},
"method": {
"type": "string",
"const": "POST"
},
"headers": {
"type": "object",
"additionalProperties": {
"type": "string"
}
}
},
"additionalProperties": false
},
"output": {
"type": "object",
"required": [
"type"
],
"properties": {
"type": {
"type": "string"
},
"example": {
"type": "object"
}
}
}
}
}
}
}Provenance
- Seen in the source catalog
- 2026-09-02 01:19Z
- Last indexed by Roundhouse
- 2026-09-07 06:20Z
- Last enriched (probe, favicon, geo)
- 2026-09-10 16:15Z
- x402 version
- 2
- Max timeout
- 600s
- Liveness probe
- HTTP 0
Hand this page to an agent
Copy the prompt and paste it into Claude, an MCP client or your own agent — it will vet this service and call it over the free read API. No key, no account.
GET api.roundhouseai.io/v0/endpoints
This endpoint's own trailing-30-day call count, as published by the upstream catalog and snapshotted daily. 8 snapshots so far. Verified volume counts only settlements with an on-chain EIP-3009 marker.
Show the promptHide the prompt
Using Roundhouse, look up the x402 service magent and tell me whether it is worth paying: what a call costs, whether the endpoint answered when last probed, and what its payment record actually shows. curl -s 'https://api.roundhouseai.io/v0/endpoints?q=magent' curl -s 'https://api.roundhouseai.io/v0/merchants/<the payTo wallet returned above>' Then call it: read the price from the live 402 at https://api.magentlab.com/api/calc/iwg2_ad, never from a cached figure, and pay with an x402 client. The /v0 API needs an API key (`authorization: Bearer rh_live_…`) on everything except /v0/unified* and /v0/endpoints. Mint a personal key for $0.01 at GET https://api.roundhouseai.io/v0/test/x402, or use an organization key from https://roundhouseai.io/dashboard/team. If you do not have Roundhouse tools or skills installed, read https://roundhouseai.io/skill.md first — it is the whole procedure.